Key statistics
As of last trade, Pulmonx Corp (4NI:DUS) traded at 6.50, 30.52% above the 52 week low of 4.98 set on Aug 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.50 |
---|---|
High | 6.50 |
Low | 6.50 |
Bid | 6.65 |
Offer | 6.85 |
Previous close | 6.70 |
Average volume | 9.00 |
---|---|
Shares outstanding | 39.49m |
Free float | 37.45m |
P/E (TTM) | -- |
Market cap | 277.60m USD |
EPS (TTM) | -1.47 USD |
Data delayed at least 15 minutes, as of Nov 13 2024 11:31 GMT.
More ▼
Announcements
- Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Pulmonx to Present at the Stifel 2024 Healthcare Conference
- Pulmonx Reports Third Quarter 2024 Financial Results
- Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
- Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
- Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference
- Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference
- Pulmonx Reports Second Quarter 2024 Financial Results
- Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
- Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
More ▼